Infectious Diseases Society of America position paper: recommended revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) sepsis quality measure.
Open accessThe DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.
Abstract
The Centers for Medicare & Medicaid Services’ Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) measure has appropriately established sepsis as a national priority. However, the Infectious Diseases Society of America (IDSA and five additional endorsing societies) is concerned about SEP-1’s potential to drive antibiotic overuse because it does not account for the high rate of sepsis overdiagnosis and encourages aggressive antibiotics for all patients with possible sepsis, regardless of the certainty of diagnosis or severity of illness. IDSA is also concerned that SEP-1’s complex “time zero” definition is not evidence-based and is prone to inter-observer variation. In this position paper, IDSA outlines several recommendations aimed at reducing the risk of unintended consequences of SEP-1 while maintaining focus on its evidence-based elements. IDSA’s core recommendation is to limit SEP-1 to septic shock, for which the evidence supporting the benefit of immediate antibiotics is greatest. Prompt empiric antibiotics are often appropriate for suspected sepsis without shock, but IDSA believes there is too much heterogeneity and difficulty defining this population, uncertainty about the presence of infection, and insufficient data on the necessity of immediate antibiotics to support a mandatory treatment standard for all patients in this category. IDSA believes guidance on managing possible sepsis without shock is more appropriate for guidelines that can delineate the strengths and limitations of supporting evidence and allow clinicians discretion in applying specific recommendations to individual patients. Removing sepsis without shock from SEP-1 will mitigate the risk of unnecessary antibiotic prescribing for noninfectious syndromes, simplify data abstraction, increase measure reliability, and focus attention on the population most likely to benefit from immediate empiric broad-spectrum antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several professional societies, including the Infectious Diseases Society of America, have recently encouraged regulators and guideline developers to provide more specific direction about which patients with possible sepsis require immediate broad-spectrum antibiotics, which can safely be managed with narrower spectrum regimens, and which can be managed without antibiotics while obtaining further”
From Trends in empiric broad-Spectrum antibiotic use for suspected community-onset Sepsis in US hospitals (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The three hour window was chosen to match the treatment window recommended by the Centers for Medicare and Medicaid Services (CMS) sepsis core measure (SEP-1) and the Surviving Sepsis Campaign guidelines 36,62,63 .”
From Factors driving provider adoption of the TREWS machine learning-based early warning system and its effects on sepsis treatment timing (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The increasing emphasis on administering immediate antibiotics to all patients with possible sepsis may therefore be driving increased use of unnecessarily broad-spectrum antibiotics, antibiotic-associated adverse events, and antimicrobial resistance without benefitting patients.”
From Trends in empiric broad-Spectrum antibiotic use for suspected community-onset Sepsis in US hospitals (2024) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 1×
“IDSA believes a 1-hour treatment target is plausible and justifiable, compared to 3 hours, given the urgency of septic shock [10, 38, 41, 43].”
BackgroundAntibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
A randomized trial of protocol-based care for early septic shock.
The ProCESS Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401602 · Cited by 2,414
Time to treatment and mortality during mandated emergency care for sepsis.
Seymour, C. W., Gesten, F., Prescott, H. C., Friedrich, M. E., Iwashyna, T. J., Phillips, G. S., Lemeshow, S., Osborn, T., Terry, K. M., & Levy, M. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703058 · Cited by 2,225 · cited 5×
“There are 2 major lines of evidence that are used to support the mandated roll-out of bundled sepsis care: (1) before/after studies that demonstrate a reduction in sepsis mortality after bundle implementation [51–56]; and/or (2) studies of association that report lower mortality rates in sepsis patients who received b…”
BackgroundResultInfluentialGoal-Directed Resuscitation for Patients with Early Septic Shock
The ARISE Investigators and the ANZICS Clinical Trials Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404380 · Cited by 2,028
Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.
Rhee, C., Dantes, R., Epstein, L., Murphy, D. J., Seymour, C. W., Iwashyna, T. J., Kadri, S. S., Angus, D. C., Danner, R. L., Fiore, A. E., et al. (2017) · JAMA · doi:10.1001/jama.2017.13836 · Cited by 1,884
Self-citationTrial of early, goal-directed resuscitation for septic shock.
Mouncey, P. R., Osborn, T. M., Power, G. S., Harrison, D. A., Sadique, M. Z., Grieve, R. D., Jahan, R., Harvey, S. E., Bell, D., Bion, J. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500896 · Cited by 1,604
Mortality after Fluid Bolus in African Children with Severe Infection
Maitland, K., Kiguli, S., Opoka, R. O., Engoru, C., Olupot-Olupot, P., Akech, S. O., Nyeko, R., Mtove, G., Reyburn, H., Lang, T., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1101549 · Cited by 1,592
Feinstein, A. R., Sosin, D. M., & Wells, C. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506203122504 · Cited by 1,544 · cited 1×
“This leads to the increased detection of patients with milder forms of sepsis and, thus, an increase in the overall number of sepsis cases and a parallel decrease in mortality [58].”
BackgroundFerrer, R., Martin-Loeches, I., Phillips, G., Osborn, T. M., Townsend, S., Dellinger, R. P., Artigas, A., Schorr, C., & Levy, M. M. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000330 · Cited by 1,480 · cited 1×
“The 2 studies cited by the guidelines that did include patients without shock were nonetheless still restricted to intensive care unit patients, were dominated by septic shock, and did not report on the association between time-to-antibiotics and mortality in the nonshock subpopulation [37, 40].”
BackgroundThe surviving sepsis campaign bundle: 2018 update
Levy, M. M., Evans, L. E., & Rhodes, A. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5085-0 · Cited by 1,445
The timing of early antibiotics and hospital mortality in sepsis.
Liu, V. X., Fielding-Singh, V., Greene, J. D., Baker, J. M., Iwashyna, T. J., Bhattacharya, J., & Escobar, G. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1848oc · Cited by 1,006 · cited 5×
“There are 2 major lines of evidence that are used to support the mandated roll-out of bundled sepsis care: (1) before/after studies that demonstrate a reduction in sepsis mortality after bundle implementation [51–56]; and/or (2) studies of association that report lower mortality rates in sepsis patients who received b…”
BackgroundResultInfluentialSerum lactate is associated with mortality in severe sepsis independent of organ failure and shock*
Mikkelsen, M. E., Miltiades, A. N., Gaieski, D. F., Goyal, M., Fuchs, B. D., Shah, C. V., Bellamy, S. L., & Christie, J. D. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819fcf68 · Cited by 999
Gaieski, D. F., Mikkelsen, M. E., Band, R. A., Pines, J. M., Massone, R., Furia, F. F., Shofer, F. S., & Goyal, M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cc4824 · Cited by 970
Levy, M. M., Dellinger, R. P., Townsend, S. R., Linde-Zwirble, W. T., Marshall, J. C., Bion, J., Schorr, C., Artigas, A., Ramsay, G., Beale, R., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181cb0cdc · Cited by 950
Hernández, G., Ospina-Tascón, G. A., Damiani, L. P., Estenssoro, E., Dubin, A., Hurtado, J., Friedman, G., Castro, R., Alegría, L., Teboul, J.-L., et al. (2019) · JAMA · doi:10.1001/jama.2019.0071 · Cited by 946
Fagon, J.-Y., Chastre, J., Wolff, M., Gervais, C., Parer-Aubas, S., Stéphan, F., Similowski, T., Mercat, A., Diehl, J.-L., Sollet, J.-P., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-8-200004180-00004 · Cited by 854
Association of adverse events with antibiotic use in hospitalized patients.
Tamma, P. D., Avdic, E., Li, D. X., Dzintars, K., & Cosgrove, S. E. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.1938 · Cited by 800
Self-citationThe Surviving Sepsis Campaign Bundle: 2018 Update
Levy, M. M., Evans, L. E., & Rhodes, A. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003119 · Cited by 679 · cited 1×
“IDSA notes that emergency department triage time has been proposed as a potential time zero for sepsis [87].”
BackgroundSurviving Sepsis Campaign: Association Between Performance Metrics and Outcomes in a 7.5-Year Study
Levy, M. M., Rhodes, A., Phillips, G. S., Townsend, S. R., Schorr, C. A., Beale, R., Osborn, T., Lemeshow, S., Chiche, J.-D., Artigas, A., et al. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000723 · Cited by 566
Kelm, D. J., Perrin, J. T., Cartin-Ceba, R., Gajic, O., Schenck, L., & Kennedy, C. C. (2015) · Shock · doi:10.1097/shk.0000000000000268 · Cited by 389
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw217 · Cited by 388 · cited 2×
“Lastly, IDSA encourages the use of daily antibiotic “timeouts” to assess the appropriateness of currently prescribed antibiotics and whether they can be de-escalated or stopped [92].”
BackgroundSelf-citationBranch-Elliman, W., O’Brien, W., Strymish, J., Itani, K., Wyatt, C., & Gupta, K. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2019.0569 · Cited by 381
Occult hypoperfusion and mortality in patients with suspected infection
Howell, M. D., Donnino, M., Clardy, P., Talmor, D., & Shapiro, N. I. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0680-5 · Cited by 356
Prehospital antibiotics in the ambulance for sepsis: A multicentre, open label, randomised trial.
Alam, N., Oskam, E., Stassen, P. M., Exter, P. V., van de Ven, P. M., Haak, H. R., Holleman, F., Zanten, A. V., Leeuwen-Nguyen, H. V., Bon, V., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30469-1 · Cited by 290 · cited 1×
“To date, the only randomized trial that has examined differential timing of antibiotics in sepsis compared prehospital antibiotic administrations versus antibiotics in the emergency department [48].”
BackgroundScheer, C. S., Fuchs, C., Gründling, M., Vollmer, M., Bast, J., Bohnert, J. A., Zimmermann, K., Hahnenkamp, K., Rehberg, S., & Kuhn, S.-O. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.05.016 · Cited by 283
Klein Klouwenberg, P. M. C., Cremer, O. L., van Vught, L. A., Ong, D. S. Y., Frencken, J. F., Schultz, M. J., Bonten, M. J., & van der Poll, T. (2015) · Critical Care · doi:10.1186/s13054-015-1035-1 · Cited by 281 · cited 1×
“A regulatory emphasis on sepsis may also predispose clinicians to prematurely favor infectious diagnoses and, thus, delay the identification of serious, noninfectious conditions [19, 22].”
Multicenter Implementation of a Severe Sepsis and Septic Shock Treatment Bundle
Miller, R. R., Dong, L., Nelson, N. C., Brown, S. M., Kuttler, K. G., Probst, D. R., Allen, T. L., & Clemmer, T. P. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201212-2199oc · Cited by 253
Vaughn, V. M., Flanders, S. A., Snyder, A., Conlon, A., Rogers, M. A. M., Malani, A. N., McLaughlin, E., Bloemers, S., Srinivasan, A., Nagel, J., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m18-3640 · Cited by 247
ED door-to-antibiotic time and long-term mortality in sepsis.
Peltan, I. D., Brown, S. M., Bledsoe, J. R., Sorensen, J., Samore, M. H., Allen, T. L., & Hough, C. L. (2019) · Chest · doi:10.1016/j.chest.2019.02.008 · Cited by 243 · cited 1×
“A third large study, which was limited almost exclusively to patients without shock, found that the risk for hospital death only clearly and consistently increased after intervals of ≥5 hours from presentation [44].”
BackgroundBloos, F., Thomas-Rüddel, D., Rüddel, H., Engel, C., Schwarzkopf, D., Marshall, J. C., Harbarth, S., Simon, P., Riessen, R., Keh, D., et al. (2014) · Critical Care · doi:10.1186/cc13755 · Cited by 240
Cheng, M. P., Stenstrom, R., Paquette, K., Stabler, S. N., Akhter, M., Davidson, A. C., Gavric, M., Lawandi, A., Jinah, R., Saeed, Z., et al. (2019) · Annals of Internal Medicine · doi:10.7326/m19-1696 · Cited by 238
Kett, D. H., Cano, E., Quartin, A. A., Mangino, J. E., Zervos, M. J., Peyrani, P., Cely, C. M., Ford, K. D., Scerpella, E. G., & Ramirez, J. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70314-5 · Cited by 235
Hranjec, T., Rosenberger, L. H., Swenson, B., Metzger, R., Flohr, T. R., Politano, A. D., Riccio, L. M., Popovsky, K. A., & Sawyer, R. G. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70151-2 · Cited by 231
Surgical delay is a critical determinant of survival in perforated peptic ulcer.
Buck, D. L., Vester-Andersen, M., & Møller, M. H. (2013) · British Journal of Surgery · doi:10.1002/bjs.9175 · Cited by 223
Misdiagnosis of Community-Acquired Pneumonia and Inappropriate Utilization of Antibiotics
Kanwar, M., Brar, N., Khatib, R., & Fakih, M. G. (2007) · Chest · doi:10.1378/chest.07-0164 · Cited by 221
Whiles, B. B., Deis, A. S., & Simpson, S. Q. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002262 · Cited by 213 · cited 1×
“A recent analysis did report that each hour delay in antibiotics in sepsis without shock was associated with an increased risk of progression to septic shock [42].”
BackgroundAzuhata, T., Kinoshita, K., Kawano, D., Komatsu, T., Sakurai, A., Chiba, Y., & Tanjho, K. (2014) · Critical Care · doi:10.1186/cc13854 · Cited by 206
Impact of antimicrobial therapy on the gut microbiome
Bhalodi, A. A., van Engelen, T. S. R., Virk, H. S., & Wiersinga, W. J. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky530 · Cited by 198
Elligsen, M., Walker, S. A. N., Pinto, R., Simor, A., Mubareka, S., Rachlis, A., Allen, V., & Daneman, N. (2012) · Infection Control & Hospital Epidemiology · doi:10.1086/664757 · Cited by 196
Impact of source control in patients with severe sepsis and septic shock.
Martínez, M. L., Ferrer, R., Torrents, E., Guillamat-Prats, R., Gomà, G., Suárez, D., Álvarez-Rocha, L., Pozo Laderas, J. C., Martín-Loeches, I., Levy, M. M., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002011 · Cited by 192
Teshome, B. F., Vouri, S. M., Hampton, N., Kollef, M. H., & Micek, S. T. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2201 · Cited by 190
Diagnosing sepsis is subjective and highly variable: A survey of intensivists using case vignettes.
Rhee, C., Kadri, S. S., Danner, R. L., Suffredini, A. F., Massaro, A. F., Kitch, B. T., Lee, G., & Klompas, M. (2016) · Critical Care · doi:10.1186/s13054-016-1266-9 · Cited by 187 · cited 1×
“Sepsis quality measures carry similar risks, since the signs and symptoms of sepsis, like those of pneumonia, are nonspecific and often subjective, especially in the first hours after presenting for care [18].”
BackgroundSelf-citationAntibiotics for sepsis-finding the equilibrium.
Klompas, M., Calandra, T., & Singer, M. (2018) · JAMA · doi:10.1001/jama.2018.12179 · Cited by 183 · cited 2×
“Recommended Revisions to the National SEP-1 Sepsis Quality Measure • cid 2021:72 (15 February) • 545 ambiguous, in many cases clinicians can safely take additional time to obtain laboratory and imaging results and assess the impact of nonantibiotic therapies; even a few short hours can be highly informative in helping…”
BackgroundSelf-citationWachter, R. M., Flanders, S. A., Fee, C., & Pronovost, P. J. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-1-200807010-00007 · Cited by 180 · cited 1×
“This measure was recommended on the basis of retrospective analyses of patients with pneumonia discharge diagnosis codes, rather than randomized trials of early intervention versus usual care for patients with possible pneumonia [13].”
MethodGu, W.-J., Zhang, Z., & Bakker, J. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3955-2 · Cited by 175 · cited 1×
“Recommended Revisions to the National SEP-1 Sepsis Quality Measure • cid 2021:72 (15 February) • 547 therapy reported a possible benefit for measuring lactate [77], but a recent randomized trial found that resuscitation informed by the physical examination of peripheral perfusion was associated with similar 28-day mor…”
BackgroundRhee, C., Murphy, M. V., Li, L., Platt, R., Klompas, M., & Program, F. T. C. F. D. C. A. P. E. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu750 · Cited by 175
Self-citationFilbin, M. R., Lynch, J., Gillingham, T. D., Thorsen, J. E., Pasakarnis, C. L., Nepal, S., Matsushima, M., Rhee, C., Heldt, T., & Reisner, A. T. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003260 · Cited by 167
Self-citationAndrews, B., Muchemwa, L., Kelly, P., Lakhi, S., Heimburger, D. C., & Bernard, G. R. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000541 · Cited by 166
Carignan, A., Allard, C., Pépin, J., Cossette, B., Nault, V., & Valiquette, L. (2008) · Clinical Infectious Diseases · doi:10.1086/588291 · Cited by 161
Heffner, A. C., Horton, J. M., Marchick, M. R., & Jones, A. E. (2010) · Clinical Infectious Diseases · doi:10.1086/650580 · Cited by 157
Whittaker, S.-A., Mikkelsen, M. E., Gaieski, D. F., Koshy, S., Kean, C., & Fuchs, B. D. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827466f1 · Cited by 156 · cited 1×
“This creates a bias towards individuals with more severe illnesses (since sepsis codes tend to be preferentially applied to sicker patients) and ignores the possible harms caused to patients initially treated for possible sepsis but subsequently found to have noninfectious diagnoses [47].”
BackgroundKahn, J. M., Davis, B. S., Yabes, J. G., Chang, C.-C. H., Chong, D. H., Hershey, T. B., Martsolf, G. R., & Angus, D. C. (2019) · JAMA · doi:10.1001/jama.2019.9021 · Cited by 149 · cited 3×
“Furthermore, many before/after studies only analyzed outcomes in patients diagnosed with sepsis and did not report on the outcomes and potential adverse effects of aggressive fluids and antibiotics in patients ultimately diagnosed with noninfectious conditions [56].”
BackgroundInfluentialKalil, A. C., Johnson, D. W., Lisco, S. J., & Sun, J. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002235 · Cited by 138 · cited 1×
“IDSA believes a 1-hour treatment target is plausible and justifiable, compared to 3 hours, given the urgency of septic shock [10, 38, 41, 43].”
BackgroundSelf-citationLevy, M. M., Gesten, F. C., Phillips, G. S., Terry, K. M., Seymour, C. W., Prescott, H. C., Friedrich, M., Iwashyna, T. J., Osborn, T., & Lemeshow, S. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2545oc · Cited by 137 · cited 2×
“Several studies, including analyses of the Surviving Sepsis Campaign database and New York State cohort, have reported associations between higher bundle compliance or time-tobundle completion and lower risk-adjusted mortality rates [41, 43, 55, 57].”
BackgroundResultRhee, C., Filbin, M. R., Massaro, A. F., Bulger, A. L., McEachern, D., Tobin, K. A., Kitch, B. T., Thurlo-Walsh, B., Kadar, A., Koffman, A., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003261 · Cited by 130
Self-citationRhee, C., Wang, R., Zhang, Z., Fram, D., Kadri, S. S., & Klompas, M. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003817 · Cited by 122 · cited 1×
“Similarly, patients who develop sepsis while in the hospital are less likely to receive bundlecompliant care but are also more severely ill and at higher risk of death [64].”
BackgroundSelf-citationBarie, P. S., Hydo, L. J., Shou, J., Larone, D. H., & Eachempati, S. R. (2005) · Surgical Infections · doi:10.1089/sur.2005.6.41 · Cited by 119 · cited 1×
“The 2 studies cited by the guidelines that did include patients without shock were nonetheless still restricted to intensive care unit patients, were dominated by septic shock, and did not report on the association between time-to-antibiotics and mortality in the nonshock subpopulation [37, 40].”
BackgroundTellor, B., Skrupky, L. P., Symons, W., High, E., Micek, S. T., & Mazuski, J. E. (2015) · Surgical Infections · doi:10.1089/sur.2014.166 · Cited by 117
The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS): A Randomized Pilot Study*
Corl, K. A., Prodromou, M., Merchant, R. C., Gareen, I., Marks, S., Banerjee, D., Amass, T., Abbasi, A., Delcompare, C., Palmisciano, A., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003779 · Cited by 116
Improving sepsis treatment by embracing diagnostic uncertainty.
Prescott, H. C., & Iwashyna, T. J. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201809-646ps · Cited by 110 · cited 1×
“Recommended Revisions to the National SEP-1 Sepsis Quality Measure • cid 2021:72 (15 February) • 545 ambiguous, in many cases clinicians can safely take additional time to obtain laboratory and imaging results and assess the impact of nonantibiotic therapies; even a few short hours can be highly informative in helping…”
BackgroundOng, D. S. Y., Frencken, J. F., Klein Klouwenberg, P. M. C., Juffermans, N., van der Poll, T., Bonten, M. J. M., & Cremer, O. L. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix186 · Cited by 109
Lee, T. C., Frenette, C., Jayaraman, D., Green, L., & Pilote, L. (2014) · Annals of Internal Medicine · doi:10.7326/m13-3016 · Cited by 95
Karvellas, C. J., Abraldes, J. G., Zepeda‐Gomez, S., Moffat, D. C., Mirzanejad, Y., Vazquez‐Grande, G., Esfahani, E. K., Kumar, A., & the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13764 · Cited by 94
Impact of Policies on the Rise in Sepsis Incidence, 2000–2010
Gohil, S. K., Cao, C., Phelan, M., Tjoa, T., Rhee, C., Platt, R., & Huang, S. S. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ1019 · Cited by 89
Self-citationRhee, C., Jentzsch, M. S., Kadri, S. S., Seymour, C. W., Angus, D. C., Murphy, D. J., Martin, G. S., Dantes, R. B., Epstein, L., Fiore, A. E., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003554 · Cited by 85 · cited 1×
“Ironically, sepsis mortality rates were still higher in New York State at the end of the intervention period, compared to control states, which may reflect variation in coding practices rather than true differences in mortality and, thus, underscores the difficulty of using administrative data to evaluate sepsis initi…”
BackgroundSelf-citationEarly fluid accumulation in children with shock and ICU mortality: a matched case–control study
Bhaskar, P., Dhar, A. V., Thompson, M. T., Quigley, R. P., & Modem, V. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3851-9 · Cited by 80
Evidence Behind the 4-Hour Rule for Initiation of Antibiotic Therapy in Community-Acquired Pneumonia
Yu, K. T., & Wyer, P. C. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.10.022 · Cited by 80
Pepper, D. J., Jaswal, D., Sun, J., Welsh, J., Natanson, C., & Eichacker, P. Q. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2947 · Cited by 79
Kushimoto, S., Abe, T., Ogura, H., Shiraishi, A., Saitoh, D., Fujishima, S., Mayumi, T., Hifumi, T., Shiino, Y., Nakada, T., et al. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003688 · Cited by 73
Whippy, A., Skeath, M., Crawford, B., Adams, C. L., Marelich, G. P., Alamshahi, M., & Borbon, J. (2011) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(11)37061-4 · Cited by 72
Henning, D. J., Carey, J. R., Oedorf, K., Day, D. E., Redfield, C. S., Huguenel, C. J., Roberts, J. C., Sánchez, L. D., Wolfe, R. E., & Shapiro, N. I. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002311 · Cited by 65
Faust, J. S., & Weingart, S. D. (2016) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2016.09.006 · Cited by 64 · cited 1×
“These criteria were adapted from the 2012 Surviving Sepsis Campaign Guidelines, but there is no clear evidence supporting the specific organ dysfunctions or thresholds chosen [69, 70].”
MethodCannon, C. M., Holthaus, C. V., Zubrow, M. T., Posa, P., Gunaga, S., Kella, V., Elkin, R., Davis, S., Turman, B., Weingarten, J., et al. (2013) · Journal of Intensive Care Medicine · doi:10.1177/0885066612453025 · Cited by 63
Truong, T.-T. N., Dunn, A. S., McCardle, K., Glasser, A., Huprikar, S., Poor, H., Raucher, B., & Poeran, J. (2019) · Journal of Critical Care · doi:10.1016/j.jcrc.2019.02.006 · Cited by 54 · cited 2×
“Clinicians are less likely to administer bundle-compliant fluid volumes to patients with heart failure, chronic kidney disease, or cirrhosis, thus raising the question of whether higher mortality rates in bundle–noncompliant patients are due to noncompliance with the bundle or these patients’ underlying comorbidities…”
BackgroundRand, K. H., Beal, S. G., Rivera, K., Allen, B. R., Payton, T. F., & Lipori, G. P. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz179 · Cited by 53
Rhee, C., Brown, S. R., Jones, T. M., O’Brien, C., Pande, A., Hamad, Y., Bulger, A. L., Tobin, K. A., Massaro, A. F., Anderson, D. J., et al. (2018) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2018.134 · Cited by 51 · cited 2×
“For example, abstractors in 1 study only agreed on time zero in 36% of cases; this led to an almost 2-fold difference in perceived SEP-1 bundle compliance rates [72].”
BackgroundSelf-citationLiu, P., Ohl, C., Johnson, J., Williamson, J., Beardsley, J., & Luther, V. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-2080-3 · Cited by 47 · cited 1×
“Failure to de-escalate empiric broad-spectrum therapy is common, even when cultures are negative [24].”
BackgroundHan, X., Edelson, D. P., Snyder, A., Pettit, N., Sokol, S., Barc, C., Howell, M. D., & Churpek, M. M. (2018) · Chest · doi:10.1016/j.chest.2018.03.025 · Cited by 47
Pepper, D. J., Sun, J., Cui, X., Welsh, J., Natanson, C., & Eichacker, P. Q. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003892 · Cited by 47
Hiensch, R., Poeran, J., Saunders-Hao, P., Adams, V., Powell, C. A., Glasser, A., Mazumdar, M., & Patel, G. (2017) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.04.005 · Cited by 44 · cited 1×
“difficile rates after instituting aggressive screening and treatment protocols for sepsis [32, 33].”
BackgroundImpact of a Prescriber-driven Antibiotic Time-out on Antibiotic Use in Hospitalized Patients
Thom, K. A., Tamma, P. D., Harris, A. D., Dzintars, K., Morgan, D. J., Li, S., Pineles, L., Srinivasan, A., Avdic, E., & Cosgrove, S. E. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy852 · Cited by 44
Self-citationNicks, B. A., Manthey, D. E., & Fitch, M. T. (2009) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2008.00320.x · Cited by 43 · cited 1×
“Clinicians admitted that they felt compelled to prescribe potentially unnecessary antibiotics to patients with ambiguous syndromes rather than risk being penalized for failing to prescribe antibiotics for the subset of patients later found to have pneumonia [17].”
BackgroundTime to antibiotics and the outcome of patients with septic shock: A propensity score analysis.
Ko, B. S., Choi, S.-H., Kang, G. H., Shin, T. G., Kim, K., Jo, Y. H., Ryoo, S. M., Kim, Y.-J., Park, Y. S., Kwon, W. Y., et al. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.09.012 · Cited by 42
Filbin, M. R., Thorsen, J. E., Zachary, T., Lynch, J. C., Matsushima, M., Belsky, J., Heldt, T., & Reisner, A. T. (2019) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2019.07.017 · Cited by 40 · cited 1×
“More than 50% of septic patients do not meet SEP-1 criteria until more than an hour after arriving in the emergency department, and even patients admitted with septic shock often do not have hypotension or explicit signs of infection at triage [88, 89].”
BackgroundKashiouris, M. G., Zemore, Z., Kimball, Z., Stefanou, C., Fowler, A. A., Fisher, B., de Wit, M., Pedram, S., & Sessler, C. N. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003921 · Cited by 35 · cited 1×
“Hospitals also need to be attentive to their systems for delivering antibiotics once they have been ordered [90, 91].”
BackgroundVillar, J., Clement, J. P., Stotts, J., Linnen, D. T., Rubin, D. J., Thompson, D. A., Gomez, A., & Fee, C. R. (2014) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2014.02.023 · Cited by 31 · cited 1×
“More than 50% of septic patients do not meet SEP-1 criteria until more than an hour after arriving in the emergency department, and even patients admitted with septic shock often do not have hypotension or explicit signs of infection at triage [88, 89].”
BackgroundAaronson, E. L., Filbin, M. R., Brown, D. F. M., Tobin, K., & Mort, E. A. (2017) · The Journal of Emergency Medicine · doi:10.1016/j.jemermed.2016.08.009 · Cited by 26 · cited 3×
“The complexity of SEP-1’s time zero criteria means it can take chart abstractors several hours per chart to identify this moment [5].”
BackgroundInfluentialA Role for Antimicrobial Stewardship in Clinical Sepsis Pathways: a Prospective Interventional Study
Burston, J., Adhikari, S., Hayen, A. D., Doolan, H., Kelly, M. L., Fu, K., Jensen, T. Ø., & Koneçny, P. (2017) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.139 · Cited by 26
Seetharaman, S., Wilson, C., Landrum, M., Qasba, S., Katz, M., Ladikos, N., Harris, J. E., Galiatsatos, P., Yousem, D. M., Knight, A. M., et al. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.01.032 · Cited by 22 · cited 1×
“difficile rates after instituting aggressive screening and treatment protocols for sepsis [32, 33].”
BackgroundQuattromani, E. N., Powell, E. S., Khare, R. K., Cheema, N., Zachrison, K. S., Periyanayagam, U., Pirotte, M. J., Feinglass, J. M., & Courtney, D. M. (2011) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2011.01053.x · Cited by 20
Sepsis and the theory of relativity: measuring a moving target with a moving measuring stick
Klompas, M., & Rhee, C. (2016) · Critical Care · doi:10.1186/s13054-016-1559-z · Cited by 16
Self-citationPepper, D. J., Natanson, C., & Eichacker, P. Q. (2018) · Annals of Internal Medicine · doi:10.7326/l18-0140 · Cited by 12
Bauer, S. R., Gonet, J. A., Rosario, R. F., Griffiths, L. A., Kingery, T., & Reddy, A. J. (2019) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2018.10.002 · Cited by 12 · cited 2×
“Given these challenges, it is unsurprising that abstractors frequently disagree on time zero [71, 72].”
BackgroundElevated Lactate Levels in a Non–Critically Ill Patient
Chen, M., Kim, T. Y., & Pessegueiro, A. M. (2015) · JAMA · doi:10.1001/jama.2014.14074 · Cited by 11 · cited 1×
“Lactate can be elevated in any condition that causes shock, as well as in malignancies, renal or liver disease, drug or toxin ingestions, and congenital enzyme deficiencies [79].”
BackgroundAntibiotic Order-to-Infusion Time for Patients With Septic Shock: A Potential New Quality Metric*
Klompas, M., & Rhee, C. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003940 · Cited by 9 · cited 1×
“Hospitals also need to be attentive to their systems for delivering antibiotics once they have been ordered [90, 91].”
BackgroundSelf-citationTownsend, S. R., Tefera, L., & Rivers, E. P. (2018) · Annals of Internal Medicine · doi:10.7326/l18-0139 · Cited by 6
Cited by
Adams, R., Henry, K. E., Sridharan, A., Soleimani, H., Zhan, A., Rawat, N., Johnson, L., Hager, D. N., Cosgrove, S. E., Markowski, A., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01894-0 · Cited by 365
“Sepsis is highly heterogeneous 24 , and there is evidence that the importance of early antibiotic therapy is similarly heterogeneous 7,25 .”
BackgroundSelf-citationEpidemiology of sepsis and septic shock
Chiu, C., & Legrand, M. (2021) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000958 · Cited by 232
Sepsis: diagnosis and management
Gauer, R. L., Forbes, D. A., & Boyer, N. L. (2024) · Pharmaceutical journal/The pharmaceutical journal · doi:10.1211/pj.2024.1.323850 · Cited by 205
Blood Culture Utilization in the Hospital Setting: a Call for Diagnostic Stewardship
Fabre, V., Carroll, K. C., & Cosgrove, S. E. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01005-21 · Cited by 180
“the core measure may result in overuse of blood cultures and antibiotics (2).”
BackgroundSelf-citationIm, Y., Kang, D., Ko, R.-E., Lee, Y. J., Lim, S. Y., Park, S., Na, S. J., Chung, C. R., Park, M. H., Oh, D. K., et al. (2022) · Critical Care · doi:10.1186/s13054-021-03883-0 · Cited by 173
Metadata
- Authors
- Rhee, C., Chiotos, K., Cosgrove, S. E., Heil, E. L., Kadri, S. S., Kalil, A. C., Gilbert, D. N., Masur, H., Septimus, E. J., Sweeney, D. A., Strich, J. R., Winslow, D. L., & Klompas, M.
- Affiliations
- Brigham and Women's Hospital (US)
- Children's Hospital of Philadelphia (US)
- Johns Hopkins University (US)
- University of Maryland, Baltimore (US)
- National Institutes of Health (US)
- Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska School of Medicine, Omaha, Nebraska, USA
- Oregon Health & Science University (US)
- Harvard University (US)
- University of California San Diego (US)
- Stanford Medicine (US)
- Corresponding author
- Masur, Henry
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-06
- Volume
- 72
- Issue
- 4
- Pages
- 541-552
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC8189682
- OpenAlex
- W3023620462
- Cited by
- 191
- References
- 103
- Citations by year
- 2026: 14 · 2025: 31 · 2024: 36 · 2023: 20 · 2022: 31 · 2021: 47 · 2020: 12
- FWCI
- 19.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- sepsis, septic shock, Centers for Medicare and Medicaid Services, antibiotic overuse, empirical antibiotic therapy, interobserver variability, broad-spectrum antibiotics
- MeSH terms
- Aged, Anti-Bacterial Agents, Communicable Diseases, Medicare, Humans, Shock, Septic, United States, Reproducibility of Results, Sepsis, Quality Indicators, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.